Find Clinical Trials
A double-blind, multicenter, international randomised study to assess the effects of 4 month-oral administration of 2g per day of strontium ranelate versus placebo on the bone quality and remodelling, as assessed on an alveolar bone biopsy extracted before dental implantation, in osteoporotic patients or in patients at risk of osteoporotic fracture.
Servier Protocol Code:
CL2-12911-039
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2011-002370-23
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Other
- S012911
- STRONTIUM RANELATE
Other study id numbers
Other identification numbers the study may be known by.
- CL2-12911-039